Showing results (931-940 of 5,930) with videos related to

Sort By:
Pageof 593
The Prostate|May 7, 2002
Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaPOskar W Rokhlin, Natalya V Guseva, Agshin F Tagiyev, et al.
The Prostate|May 7, 2002
Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cellsEva Corey, Janna E Quinn, Franck Bladou, et al.
The Prostate|May 7, 2002
High level of alpha1-acid glycoprotein in human seminal plasma is associated with high branching and expression of Lewis(a) groups on its glycans: supporting evidence for a prostatic originDennis C W Poland, Ewa Kratz, Jan P W Vermeiden, et al.
The Prostate|May 7, 2002
DNA methylation in the androgen receptor gene promoter region in rat prostate cancersSatoru Takahashi, Shingo Inaguma, Michihisa Sakakibara, et al.
The Prostate|June 1, 1995
Survival of patients with localized prostate cancer treated with percutaneous transperineal placement of radioactive gold seeds: stages A2, B, and CJ A Hochstetler, K J Kreder, C K Brown, et al.
The Prostate|October 1, 1994
Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor geneT L Burney, S Rockove, J L Eiseman, et al.
The Prostate|December 1, 1994
Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulationY Furuya, J T Isaacs
The Prostate|March 29, 2002
Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cellsZheng Fu, Igor M Dozmorov, Evan T Keller
The Prostate|April 23, 2002
Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumorsTerrence L Fisher, MaryAnn Nocera, Richard A Willis, et al.
The Prostate|April 23, 2002
Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activationTzyh-Chyuan Hour, Jun Chen, Chao-Yuan Huang, et al.
Pageof 593